Therapeutic hypothermia, or targeted temperature management, has been shown to improve outcomes for patients who remain unconscious after resuscitation from cardiac arrest. Two key studies from 2002 demonstrated improved mortality and neurological function when patients' temperatures were cooled to 32-34°C for 12-24 hours after cardiac arrest. Subsequent meta-analyses and clinical guidelines have supported induced hypothermia for unconscious cardiac arrest survivors. However, the optimal target temperature range was still unclear. A 2013 randomized controlled trial compared outcomes between unconscious cardiac arrest survivors treated with targeted temperature management at 33°C versus 36°C and found no significant difference in mortality or neurological function between the two temperature targets.
Post-Cardiac Arrest Syndrome:
Epidemiology, Pathophysiology, Treatment, and Prognostication
A Consensus Statement From the International Liaison Committee on Resuscitation
Circulation. 2008;118:2452-2483
Short description about awake craniotomy, its indications, contraindications, complications,various techniques of providing awake craniotomy and drugs used.
Post-Cardiac Arrest Syndrome:
Epidemiology, Pathophysiology, Treatment, and Prognostication
A Consensus Statement From the International Liaison Committee on Resuscitation
Circulation. 2008;118:2452-2483
Short description about awake craniotomy, its indications, contraindications, complications,various techniques of providing awake craniotomy and drugs used.
Lessons from the TTM trial and planning for the nexstscanFOAM
A presentation by Niklas Nielsen, Tobias Cronberg and Gisela Lilja at the 2017 meeting of the Scandinavian Society of Anaestesiology and Intensive Care Medicine.
All available content from SSAI2017: https://scanfoam.org/ssai2017/
Delivered in collaboration between scanFOAM, SSAI & SFAI.
Debate: Neurocritical Care Improves Outcomes in Severe TBISMACC Conference
Martin Smith and Mark Wilson debate whether neurocritical care improves outcomes in severe TBI.
Martin argues in favour of neurocritical care.
He concedes that longstanding and established practices are not as efficacious or innocuous as previously believed.
Very few specific interventions have been shown to improve outcomes in large randomised controlled trials. With the possible exception of avoidance of hypotension and hypoxaemia, most are based on analysis of physiology and pathophysiology.
Further, the substantial temporal and regional pathophysiological heterogeneity after TBI means that some interventions may be ineffective, unnecessary, or even harmful in certain patients at certain times.
Martin however, contends that improved understanding of pathophysiology and advances in neuromonitoring and imaging techniques have led to more effective and individualised treatment strategies. Ultimately, this has led to improved outcomes for patients.
In particular, the sole goal of identifying and treating intracranial hypertension has been superseded by a focus on the prevention of secondary brain insults. This is done by using a systematic, stepwise approach to maintenance of adequate cerebral perfusion and oxygenation.
Similarly, multimodal neuromonitoring also gives clinicians confidence to withhold potentially dangerous therapy. Particuarly in those with no evidence of brain ischemia/hypoxia or metabolic disturbance.
Mark Wilson on the other hand argues there is no benefit in neurocritical care following severe TBI.
The New England Journal of Medicine has published several articles that demonstrate no benefit from classic neurotrauma interventions (ICP monitoring, cooling, decompression). This is because factors such as ICP and CPP associate with bad outcomes by association rather than causation.
This debate will demonstrate that critical care just complicates things. Evidently, it is high time for the randomised trial between the very best neurocritical care and NOB therapy (Naso-pharyngeal, Oxygen and a Blanket).
Join Martin and Mark as they discuss the pros and cons of neurocritical care in the management of severe TBI.
For more like this, head to our podcast page. #CodaPodcast
SOLACI Coverage: AHA 2012 Congress. Dr. Esteban Lopez-de-Sa . PILOT trial: El estudio piloto de dos niveles de hipotermia en los sobrevivientes comatosos tras un paro cardiaco fuera del hospital. Find more presentations on our web http://solaci.org/es/aha_2012.php
How to ventilate COPD and ARDS in Intensive care unit. safe lung ventilation. PEEP, Tidal volume, mode of ventilation. limits of ventilation. ventilator alarms
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
3. Induced Hypothermia Post Cardiac Arrest
With ROSC
• In 2002, the New England Journal published two well designed
studies 1,2 showing dramatically improved outcomes when patients
are actively cooled after resuscitation from V. Fib or Pulseless V.
Tach. This led to an advisory statement by the ILCOR (International
Liaison Committee on Resuscitation) that such patients should be
cooled.
• 1. Bernard S. et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with
induced hypothermia. NEJM 2002, Feb 21; 346(8): 557-563.
• 2. The Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to
improve the neurologic outcome after cardiac arrest. NEJM 2002, Feb 21; 346(8): 549-556.
4. What does “improved outcomes” mean?
• Both studies showed improved neurologic outcomes, not just
improved mortality.
5. A Meta analysis
• Meta-analysis including these two trials and another for patients
resuscitated from PEA or asystole and cooled for 4 hours 2 .
Neurologic recovery was improved and independent of method of
cooling. Number needed to treat 4 – 13. 1.
• Holzer M, et al. Hypothermia for neuroprotection after cardiac arrest: Systemic
review and individual patient data meta-analysis. Crit Care Med, 2005; 33(2): 414418.
6. ILCOR Advisory Statement
• “ Unconscious adult patients with spontaneous circulation after outof-hospital cardiac arrest should be cooled to 32° to 34°C for 12 to 24
hours when the initial rhythm was ventricular fibrillation.” “ Such
cooling may also be beneficial for other rhythms or in-hospital cardiac
arrest.”
• International Liaison Committee on Resuscitation. Therapeutic hypothermia after cardiac
arrest – An advisory statement by the Advanced Life Support Task Force of the
International Liaison Committee on Resuscitation. Circulation 2003; 108: 118-121.
8. Why does it work? Theoretical Basis:
• Slowed cerebral metabolism decreased 5 to 7% for each degree
Centigrade reduction in body temperature. Decrease core
temperature 4°C = 20-28% reduction in cerebral metabolism.
Protective effects appear to be much greater than explained by this
mechanism alone 1,2 .
1. Milde LN. Clinical use of mild hypothermia for brain protection: a dream revisited. J.
Neurosurg Anesth 1992; 4: 211-215.
2. Small DL, et al. Biology of ischemic cerebral cell death. Prog Cardiovasc Dis, 1999; 42:
185-207.
9. Why does it work? Theoretical Basis:
• Apoptosis:
• Apoptosis involves mitochondrial dysfunction and release of destructive
intracellular enzymes. Hypothermia can prevent these two processes leading
to apoptosis
10. Why does it work? Theoretical Basis:
• Excitatory neurotoxicity
• As neurons become ischemic, they cannot maintain membrane potential,
depolarize and release glutamate.
• Energy-requiring mechanisms of re-uptake are impaired.
• Surrounding neurons are stimulated longer than normal in an ischemic state,
causing more damage.
Hypothermia is believed to stabilize cell membranes and has been shown in
animals to slow excitatory neurotoxicity
• Glutamate release and free radical production following brain injury: effects of posttraumatic hypothermia. J Neurochem, 1995; 65: 1704-1711. 4. Busto R, et al
11. Why does it work? Theoretical Basis:
• Modulation of immune response and edema
•
•
•
•
Hypothermia suppresses release of inflammatory cytokines (TNF- α and IL-1)
It also slows production of free radicals
Reduces disruptions of the blood-brain barrier, decreasing edema.
Moderate hypothermia delays proinflammatory cytokine production of
human peripheral blood mononuclear cells.
• Crit Care Med, 2002; 30: 1499-1502. 2. Globus M, et al.
12. Inclusion Criteria
Exclusion Criteria
• Non-Traumatic cardiac
arrest with return of
circulation
• TH initiated within 6 hours
of arrest
• Systolic BP > 90 or MAP >
60 after fluid resuscitation
with or without pressors
• > 12 years old
• GCS > 8
• Greater than 6 hours since
arrest
• DNR
• Non-mechanically ventilated
patient
• Pregnancy
• Active bleeding
• Arrest secondary to sepsis
18. Clinical Performance Category
• CPC 5. Brain death: apnea, areflexia, EEG silence, etc.
• CPC 4 . Coma or vegetative state: any degree of coma without the presence of
all brain death criteria. Unawareness, even if appears awake (vegetative state)
without interaction with environment; may have spontaneous eye opening
and sleep/awake cycles. Cerebral unresponsiveness.
• CPC 3. Severe cerebral disability: conscious, dependent on others for daily
support because of impaired brain function. Ranges from ambulatory state to
severe dementia or paralysis
• CPC 2. Moderate cerebral disability: conscious, sufficient cerebral function
for independent activities of daily life. Able to work in sheltered
environment
• CPC 1. Good cerebral performance: conscious, alert, able to work, might
have mild neurologic or psychologic deficit
• Lancet 1975. 1(7905):480-4
19. Hypothermia in Comatose Survivors From
Out-of-Hospital Cardiac Arrest: Pilot Trial
Comparing 2 Levels of Target Temperature
• Circulation. published online November 6, 2012;
20. Methods and Results
• Patients were eligible if they had a witnessed out-of-hospital cardiac
arrest from March 2008 to August 2011.
• Target temperature was randomly assigned to 32°C or 34°C.
• The primary outcome was survival free from severe dependence
(Barthel Index score 60 points) at 6 months.
• Thirty-six patients were enrolled in the trial (26 shockable rhythm, 10
asystole), with 18 assigned to 34°C and 18 to 32°C.
• Eight of 18 patients in the 32°C group (44.4%) met the primary end
point compared with 2 of 18 in the 34°C group (11.1%) (log-rank
P0.12).
21. Conclusions
• The findings of this pilot trial suggest that a lower cooling level may
be associated with a better outcome in patients surviving out-ofhospital cardiac arrest secondary to a shockable rhythm. The
benefits observed here merit further investigation in a larger trial in
out-of-hospital cardiac arrest patients with different presenting
rhythms.
23. Background
• Unconscious survivors of out-of-hospital cardiac arrest have a high
risk of death or poor neurologic function. Therapeutic hypothermia is
recommended by international guidelines, but the supporting
evidence is limited, and the target temperature associated with the
best outcome is unknown.
• Our objective was to compare two target temperatures, both
intended to prevent fever.
24. Methods
• International trial
• randomly assigned 950 unconscious adults after out-of-hospital
cardiac arrest of presumed cardiac cause to targeted temperature
management at either 33°C or 36°C.
• The primary outcome was all-cause mortality through the end of the
trial.
• Secondary outcomes included a composite of poor neurologic
function or death at 180 days, as evaluated with the Cerebral
Performance Category (CPC) scale and the modified Rankin scale.
25. Results
• 50% of the patients in the 33°C group (235 of 473 patients) had
died, as compared with 48% of the patients in the 36°C group (225 of
466 patients) (P=0.51).
• At the 180-day follow-up, 54% of the patients in the 33°C group had
died or had poor neurologic function according to the CPC, as
compared with 52% of patients in the 36°C (P=0.78).
• In the analysis using the modified Rankin scale, the comparable rate
was 52% in both groups (P=0.87).
• The results of analyses adjusted for known prognostic factors were similar.
26. Conclusions
• In unconscious survivors of out-of-hospital cardiac arrest of presumed
cardiac cause, hypothermia at a targeted temperature of 33°C did not
confer a benefit as compared with a targeted temperature of 36°C.